MEF promotes stemness in the pathogenesis of gliomas

45Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

High-grade gliomas are aggressive and uniformly fatal tumors, composed of a heterogeneous population of cells that include many with stem-cell-like properties. The acquisition of stem-like traits might contribute to glioma initiation, growth, and recurrence. Here we investigated the role of the transcription factor myeloid Elf-1 like factor (MEF, also known as ELF4) in gliomas. We found that MEF is highly expressed in both human and mouse glioblastomas and its absence impairs gliomagenesis in a PDGF-driven glioma mouse model. We show that modulation of MEF levels in both mouse neural stem cells and human glioblastoma cells has a significant impact on neurosphere formation. Moreover, we identify Sox2 as a direct downstream target of MEF. Taken together, our studies implicate MEF as a previously unrecognized gatekeeper gene in gliomagenesis that promotes stem cell characteristics through Sox2 activation. © 2012 Elsevier Inc.

Cite

CITATION STYLE

APA

Bazzoli, E., Pulvirenti, T., Oberstadt, M. C., Perna, F., Wee, B., Schultz, N., … Squatrito, M. (2012). MEF promotes stemness in the pathogenesis of gliomas. Cell Stem Cell, 11(6), 836–844. https://doi.org/10.1016/j.stem.2012.09.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free